RegulatoryInvestigation

Controversial Call from FCA: Judge's Reaction to Barclays Case Raises Eyebrows

24 days ago

A recent hearing in a high-profile case involving former Barclays CEO Jes Staley has drawn attention after a judge's bewilderment over the approach taken by the Financial Conduct Authority (FCA). The case primarily revolves around alleged misconduct during Staley’s tenure at Barclays, with the FCA’s interactions being scrutinized following a phone call that caught the court's attention.

Regulators Launch Investigation into Extent of Data Crisis in the UK

3 months ago

In a pressing response to growing concerns over the integrity and security of data management across the United Kingdom, regulatory bodies have initiated an investigation to ascertain how far-reaching the current data crisis has spread. This investigation comes amidst revelations of significant breaches and lapses in data governance that have alarmed experts and consumers alike.

B. Riley Financial Faces New SEC Subpoenas Amid Ongoing Concerns

3 months ago

In a recently disclosed filing, B. Riley Financial, a prominent financial services firm, has revealed that it is under scrutiny from the Securities and Exchange Commission (SEC) following the receipt of multiple subpoenas. This development has raised significant attention within the financial community, particularly as it involves the firm's founder, Bryant Riley.

AstraZeneca Shares Plunge Amidst Escalating Probe Concerns in China

6 months ago

AstraZeneca's stock price experienced its most significant decline in over three years, plunging sharply by 12%. This dramatic drop can be attributed to escalating fears surrounding a regulatory investigation in China involving the pharmaceutical giant. Investors reacted swiftly to the news, indicating a growing concern over potential implications for AstraZeneca’s operations and revenue in one of the world’s largest pharmaceutical markets.